{
    "id": 8816,
    "fullName": "RB1 C706F",
    "impact": "missense",
    "proteinEffect": "loss of function - predicted",
    "geneVariantDescriptions": [
        {
            "description": "RB1 C706F lies within domain B of the Rb1 protein (UniProt.org). C706F is predicted to confer a loss of function to the Rb1 protein as demonstrated by loss of Rb1 phosphorylation (PMID: 2168563).",
            "references": [
                {
                    "id": 295,
                    "pubMedId": null,
                    "title": null,
                    "url": "https://www.uniprot.org"
                },
                {
                    "id": 3196,
                    "pubMedId": 2168563,
                    "title": "A single amino acid substitution results in a retinoblastoma protein defective in phosphorylation and oncoprotein binding.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/2168563"
                }
            ]
        }
    ],
    "type": null,
    "gene": {
        "id": 5925,
        "geneSymbol": "RB1",
        "terms": [
            "RB1",
            "OSRC",
            "p105-Rb",
            "p110-RB1",
            "pp110",
            "PPP1R130",
            "pRb",
            "RB"
        ]
    },
    "variant": "C706F",
    "createDate": "07/07/2015",
    "updateDate": "09/03/2018",
    "referenceTranscriptCoordinates": {
        "id": 147545,
        "transcript": "NM_000321",
        "gDna": "chr13:g.48463741G>T",
        "cDna": "c.2117G>T",
        "protein": "p.C706F",
        "sourceDb": "RefSeq",
        "refGenomeBuild": "GRCh38/hg38"
    },
    "partnerGenes": [
        
    ],
    "evidence": [
        {
            "id": 10437,
            "approvalStatus": "Case Reports/Case Series",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a clinical case study, RB1 C706F and loss of exons 1-11 in TP53 were identified in the pericardium infiltrating small cell lung cancer that developed while on Lorlatinib (PF-06463922) treatment in a patient with ALK-rearranged non-small cell lung carcinoma (PMID: 28285684).",
            "molecularProfile": {
                "id": 27462,
                "profileName": "ALK rearrange RB1 C706F TP53 loss"
            },
            "therapy": {
                "id": 869,
                "therapyName": "Lorlatinib",
                "synonyms": null
            },
            "indication": {
                "id": 5409,
                "name": "lung small cell carcinoma",
                "source": "DOID"
            },
            "responseType": "predicted - resistant",
            "references": [
                {
                    "id": 8449,
                    "pubMedId": 28285684,
                    "title": "Dual occurrence of ALK G1202R solvent front mutation and small cell lung cancer transformation as resistance mechanisms to second generation ALK inhibitors without prior exposure to crizotinib. Pitfall of solely relying on liquid re-biopsy?",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/28285684"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        }
    ],
    "molecularProfiles": [
        {
            "id": 8710,
            "profileName": "RB1 C706F",
            "profileTreatmentApproaches": [
                {
                    "id": 5934,
                    "name": "HDAC Inhibitor",
                    "profileName": "RB1 C706F"
                }
            ]
        },
        {
            "id": 27462,
            "profileName": "ALK rearrange RB1 C706F TP53 loss",
            "profileTreatmentApproaches": [
                
            ]
        }
    ],
    "allTranscriptCoordinates": [
        {
            "id": 147545,
            "transcript": "NM_000321",
            "gDna": "chr13:g.48463741G>T",
            "cDna": "c.2117G>T",
            "protein": "p.C706F",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        }
    ]
}